MeiraGTx Holdings (MGTX) EBITDA Margin Growth (1y) (2020 - 2025)
MeiraGTx Holdings (MGTX) EBITDA Margin Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
MeiraGTx Holdings |
910.47 Mn |
844.54 Mn |
74.89 Mn |
21,050.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
21,050.00 |
| Sep 30, 2025 |
-1.17 Mn |
| Jun 30, 2025 |
1.63 Mn |
| Dec 31, 2024 |
-74,852.00 |
| Sep 30, 2024 |
37,854.00 |
| Jun 30, 2024 |
-1.65 Mn |
| Mar 31, 2024 |
-219,415.00 |
| Dec 31, 2023 |
-12,360.00 |
| Sep 30, 2023 |
-15,832.00 |
| Jun 30, 2023 |
-66,002.00 |
| Mar 31, 2023 |
-46,448.00 |
| Dec 31, 2022 |
73,920.00 |
| Sep 30, 2022 |
-25,702.00 |
| Jun 30, 2022 |
15,318.00 |
| Mar 31, 2022 |
304.00 |
| Dec 31, 2021 |
32,112.00 |
| Sep 30, 2021 |
-12,776.00 |
| Jun 30, 2021 |
60,590.00 |
| Mar 31, 2021 |
-24,113.00 |
| Dec 31, 2020 |
-22,785.00 |
